David Kabakoff
InvestorExecutive Advisor, Private Equity at Sofinnova Ventures · Board director at NextCure · Board director at Neurana Pharmaceuticals · Board director at Antiva Biosciences
About
David Kabakoff is a medicinal chemist with more than 30 years of experience leading technology and product development in the pharmaceutical, biopharmaceutical, and drug delivery fields. Before joining Sofinnova in 2007, he co-founded the cancer drug developer Salmedix, serving as Chairman and CEO until its acquisition by Cephalon, and previously held executive roles at Dura, Spiros Development, Corvas International, and Hybritech. He holds a PhD from Yale University and a BA from Case Western Reserve University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at NextCure
Intro paths
In turn, David can intro founders to NextCure's investors below.
NextCure's investors · 9
Co-founders at NextCure
Board director at Neurana Pharmaceuticals
Intro paths
In turn, David can intro founders to Neurana Pharmaceuticals's investors below.
Board director at Antiva Biosciences
Intro paths
In turn, David can intro founders to Antiva Biosciences's investors below.
Antiva Biosciences's investors · 10
__Twitter.png)
Co-founders at Antiva Biosciences
Deals · 1
RarecyteBoard seat
via Sofinnova Ventures · filed Jul 2023 · $35.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AmplimmuneAntivaAntiva BiosciencesCastle BiosciencesInterMuneNextCureNextCurePrincipiaTrius
Sources: the firm's website · SEC Form D filings.
Colleagues at Sofinnova Ventures
Frequently asked questions
- Who is David Kabakoff?
- David Kabakoff is a medicinal chemist with more than 30 years of experience leading technology and product development in the pharmaceutical, biopharmaceutical, and drug delivery fields. Before joining Sofinnova in 2007, he co-founded the cancer drug developer Salmedix, serving as Chairman and CEO until its acquisition by Cephalon, and previously held executive roles at Dura, Spiros Development, Corvas International, and Hybritech. He holds a PhD from Yale University and a BA from Case Western Reserve University.
- Where does David Kabakoff work?
- David Kabakoff is Executive Advisor, Private Equity at Sofinnova Ventures and Board director at NextCure and Board director at Neurana Pharmaceuticals and Board director at Antiva Biosciences.
- What does David Kabakoff invest in?
- David Kabakoff invests in Biotech.
- What boards does David Kabakoff sit on?
- David Kabakoff holds tracked board seats at Amplimmune, Antiva, Antiva Biosciences, Castle Biosciences, InterMune, NextCure, NextCure, Principia, Rarecyte, Rarecyte.